Literature DB >> 12943333

Utilization of complementary/alternative services by women with breast cancer.

Ross E Gray1, Margaret Fitch, Vivek Goel, Edmee Franssen, Manon Labrecque.   

Abstract

This paper reports on the utilization of complementary/alternative medicine (CAM) services by women with breast cancer. Study participants were women with invasive breast cancer diagnosed 23-36 months prior to contact about the study, and randomly selected from the Ontario Cancer Registry. From among 1,119 eligible women sent survey questionnaires, 731 returned completed questionnaires (65%). A total of 20% of respondents used at least 1 CAM service. Among those who responded to a question about whether they would have liked specific services, 39% reported that there was at least one CAM service they would have liked to use, but were unable to access. Factors shown to be related to greater utilization of services included: younger age, higher household income, employed or student status, private health insurance coverage, and having received chemotherapy. Study results speak to the importance of acknowledging that professionals outside of the formal cancer care system play an important role for many patients. Patients would welcome experimentation with service models in which CAM practitioners and cancer specialists collaborate in providing care.

Entities:  

Mesh:

Year:  2003        PMID: 12943333     DOI: 10.1300/J045v16n04_04

Source DB:  PubMed          Journal:  J Health Soc Policy        ISSN: 0897-7186


  8 in total

1.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

2.  Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Authors:  Leanna J Standish; Erin Sweet; Eleonora Naydis; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2012-06-27       Impact factor: 3.279

3.  Complementary and alternative medicine use in breast cancer patients in Europe.

Authors:  Alexander Molassiotis; Julia A Scott; Nora Kearney; Dorit Pud; Miriam Magri; Sarka Selvekerova; Ingrid Bruyns; Paz Fernadez-Ortega; Vassiliki Panteli; Anita Margulies; Gudbjorg Gudmundsdottir; Ljiljana Milovics; Gulten Ozden; Nurgun Platin; Elisabeth Patiraki
Journal:  Support Care Cancer       Date:  2005-09-06       Impact factor: 3.603

4.  Determination of parameters affecting the use of complementary and alternative medicine in cancer patients and detection of prevalence of use.

Authors:  Alpaslan Mayadagli; Atinc Aksu; Fatih Goksel; Erkan Gocen; Eray Karahacioglu; Mahmut Gumus; Yücel Pak
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

5.  Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.

Authors:  Katherine D Crew; Jillian L Capodice; Heather Greenlee; Arlyn Apollo; Judith S Jacobson; George Raptis; Kimberly Blozie; Alex Sierra; Dawn L Hershman
Journal:  J Cancer Surviv       Date:  2007-10-12       Impact factor: 4.442

6.  Use of Chinese medicine by cancer patients: a review of surveys.

Authors:  Bridget Carmady; Caroline A Smith
Journal:  Chin Med       Date:  2011-06-09       Impact factor: 5.455

Review 7.  Evaluation of effectiveness of herbal medication in cancer care: a review study.

Authors:  Javad Tavakoli; Solaleh Miar; Mohammad Majid Zadehzare; Hossein Akbari
Journal:  Iran J Cancer Prev       Date:  2012

Review 8.  The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided.

Authors:  Peter J H Beliveau; Jessica J Wong; Deborah A Sutton; Nir Ben Simon; André E Bussières; Silvano A Mior; Simon D French
Journal:  Chiropr Man Therap       Date:  2017-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.